Stock comparison
Mettler-Toledo International
ResMed
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$20.85B
Sector
Healthcare
RMD
ResMed
Market cap
$29.57B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | RMD | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 72B | RMD |
| Benjamin Graham | 64C | 75B | RMD |
| Philip Fisher | 62C | 75B | RMD |
| Peter Lynch | 66B | 58C | MTD |
| Joel Greenblatt | 66B | 47D | MTD |
| Charlie Munger | 73B | 69B | MTD |
| Terry Smith | 70B | 73B | RMD |
Side-by-side metrics
| Metric | MTD | RMD |
|---|---|---|
| Market cap | $20.85B | $29.57B |
| P/E (TTM) | 23.9x | 19.6x |
| EV/EBIT | 20.6x | 17.1x |
| ROIC (TTM) | 36.09% | 19.63% |
| Gross margin | 57.79% | 61.69% |
| Net margin | 21.4% | 27.44% |
| Revenue CAGR 5y | 2.01% | 12.64% |
| EPS CAGR 5y | 6.12% | 30.73% |
| Debt / Equity | - | 0.1x |
| Dividend yield | 0.0% | 1.14% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- Debt / Equity-vs 0.1x+100%
- ROIC (TTM)36.09%vs 19.63%+46%
RMD leads on
- Dividend yield1.14%vs 0.0%+100%
- Revenue CAGR 5y12.64%vs 2.01%+84%
- EPS CAGR 5y30.73%vs 6.12%+80%
- Market cap$29.57Bvs $20.85B+29%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.